miR-335-5p inhibited the proliferation of glucose-treated pancreatic cells and promoted apoptosis, which subsequently aggravates T2DM, by inhibiting SLC2A4 expression [37]. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.